ERLEUM Trademark

Trademark Overview

On Friday, October 4, 2019, a trademark application was filed for ERLEUM with the United States Patent and Trademark Office. The USPTO has given the ERLEUM trademark a serial number of 88642500. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 3, 2023. This trademark is owned by JOHNSON & JOHNSON. The ERLEUM trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
erleum

General Information

Serial Number88642500
Word MarkERLEUM
Filing DateFriday, October 4, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, October 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 18, 2022SOU EXTENSION 5 GRANTED
Monday, August 8, 2022SOU EXTENSION 5 FILED
Tuesday, August 16, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 8, 2022TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU EXTENSION 4 GRANTED
Friday, February 4, 2022SOU EXTENSION 4 FILED
Friday, February 4, 2022TEAS EXTENSION RECEIVED
Wednesday, November 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 7, 2021SOU EXTENSION 3 GRANTED
Monday, June 7, 2021SOU EXTENSION 3 FILED
Monday, June 7, 2021TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 12, 2021SOU EXTENSION 2 GRANTED
Friday, February 12, 2021SOU EXTENSION 2 FILED
Friday, February 12, 2021TEAS EXTENSION RECEIVED
Friday, August 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2020SOU EXTENSION 1 GRANTED
Wednesday, August 5, 2020SOU EXTENSION 1 FILED
Wednesday, August 5, 2020TEAS EXTENSION RECEIVED
Tuesday, February 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 22, 2019ASSIGNED TO EXAMINER
Tuesday, October 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 8, 2019NEW APPLICATION ENTERED

Related Keywords

erleum diseases anti system metabolic oncologic ophthalmic related intestinal infectious respiratory